| 1 |
Rondon-Berrios H, Agaba EI, Tzamaloukas AH. Hyponatremia: Pathophysiology, classification, manifestations and management[J]. Int Urol Nephrol, 2014, 46, 2153-2165.
|
| 2 |
Mohan S, Gu S, Parikh A, et al. Prevalence of hyponatremia and association with mortality: results from NHANES[J]. Am J Med, 2013, 126: 1127-1137.
|
| 3 |
Corona G, Giuliani C, Parenti G, et al. Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis[J]. PLoS ONE, 2013, 8: e80451.
|
| 4 |
Winzeler B, Jeanloz N, Nigro N, et al. Long-term outcome of profound hyponatremia: A prospective 12 months follow-up study [J]. Eur J Endocrinol, 2016, 175: 499-507.
|
| 5 |
Frenkel NJ, Vogt L, De Rooij SE, et al. Thiazide-induced hyponatraemia is associated with increased water intake and impaired urea-mediated water excretion at low plasma antidiuretic hormone and urine aquaporin-2[J]. J Hypertens, 2015, 33: 627-633.
|
| 6 |
Olsson K, Ohlin B, Melander O. Epidemiology and characteristics of hyponatremia in the emergency department[J]. Eur J Intern Med, 2013, 24: 110-116.
|
| 7 |
Zheng Y, Zheng FP, Li H. The prevalence and causes of hyponatremia in hospitalized patients[J]. Zhonghua Nei Ke Za Zhi, 2020, 59: 29-34.
|
| 8 |
Thajudeen B, Salahudeen AK. Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives[J]．. Cancer Manag Res, 2016, 8: 105-114.
|
| 9 |
Ezoe Y, Mizusawa J, Katayama H, et al. An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)[J]．. Oncotarget, 2018, 9: 6595-6606.
|
| 10 |
Liamis G, Barkas F, Megapanou E, et al. Hyponatremia in acute stroke patients: pathophysiology, clinical significance, and management options[J]. Eur Neurol, 2019, 82: 32-40.
|
| 11 |
Lu X, Wang X. Hyponatremia induced by antiepileptic drugs in patients with epilepsy[J]. Expert Opin Drug Saf, 2017, 16: 77-87.
|
| 12 |
Liang Teo DC, Mok VWL. 127 Successful treatment of major depressive disorder with moclobemide after recurrent hyponatremia induced by multiple antidepressant classes[J]. CNS Spectr, 2020, 25: 280-281.
|
| 13 |
Mackelaite L, Lederer E. Hyponatremia complicatingesophageal carcinoma: a challenging eifferential diagnosis[J]．. Am J Med Sci, 2018, 356: 567-569.
|
| 14 |
Liamis G, Filippatos TD, Liontos A, et al. MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment[J]. Eur J Endocrinol, 2017, 176: R15-R20.
|
| 15 |
Yasir M, Mechanic OJ. Syndrome of inappropriate antidiuretic hormone secretion (SIADH). StatPearls. Treasure Island (FL): StatPearls Publishing Copyright, 2020, StatPearls Publishing LLC.; 2020.
|
| 16 |
Ranpu Wu, Chuling Li, Zimu Wang, et al. A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia[J]. Transl Lung Cancer Res, 2020, 9(6): 2469-2478.
|
| 17 |
Dineen R, Thompson CJ, Sherlock M. Hyponatraemia-Presentations and management. Clinical Medicine[J]. J R Coll Physicians Lond, 2017, 17: 263-269.
|
| 18 |
Gankam Kengne F. Physiopathology, clinical diagnosis, and treatment of hyponatremia[J]. Acta Clin Belg Int J Clin Lab Med, 2016, 71: 359-372.
|
| 19 |
Smith DM, Mckenna K, Thompson CJ. Hyponatraemia[J]. Clin Endocrinol, 2000, 552: 667-678.
|
| 20 |
Hausman-Kedem M, Reif S, Danino D, et al. Mechanism of hyponatremia in community-acquired pneumonia: does b-type natriuretic peptide play a causative role? [J]. Pediatric Emerg Care, 2018, 34: 641-646.
|
| 21 |
Sahay M, Sahay R. Hyponatremia: A practical approach[J]. Indian J Endocrino Metab, 2014, 18: 760-771.
|
| 22 |
John S, Thuluvath PJ. Hyponatremia in cirrhosis: Pathophysiology and management[J]. World J. Gastroenterol, 2015, 21: 3197-3205.
|
| 23 |
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2016, 37: 2129-2200.
|
| 24 |
Renneboog B, Sattar L, Decaux G. Attention and postural balance are much more affected in older than in younger adults with mild or moderate chronic hyponatremia[J]. Eur J Intern Med, 2017, 41: e25-e26.
|
| 25 |
Kuo SC, Kuo PJ, Rau CS, et al. Hyponatremia is associated with worse outcomes from fall injuries in the elderly[J]. Int J Environ Res Public Health, 2017, 14: pii: E460.
|
| 26 |
Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations[J]. Am J Med, 2013, 126(10 suppl 1): S1-S42.
|
| 27 |
Burst V, Grundmann F, Kubacki T, et al. Thiazideassociated hyponatremia, report of the hyponatremia registry: an observational multicenter international study[J]. Am J Nephrol, 2017, 45: 420-430.
|
| 28 |
Perez CA, Figueroa SA: Complication rates of 3% hypertonic saline infusion through peripheral intravenous access[J]. J Neurosci Nurs, 2017, 49: 191-195.
|
| 29 |
Hew-Butler T, Rosner MH, Fowkes-Godek S, et al. Statement of the third international exercise-associated hyponatremia consensus development conference, Carlsbad, California, 2015[J]. Clin J Sport Med, 2015, 25: 303-320.
|
| 30 |
Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia[J]. Nephrol Dial Transplant, 2014, 170: G1-G47.
|
| 31 |
Sterns RH. Treatment of severe hyponatremia[J]. Clin J Am Soc Nephrol, 2018, 13: 641-649.
|
| 32 |
Robertson GL. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis[J]. Am J Med, 2006, 119(7 suppl 1): S36-S42.
|
| 33 |
Furst H, Hallows KR, Post J, et al. The urine/plasma electrolyte ratio: a predictive guide to water restriction[J]. Am J Med Sci, 2000, 319: 240-244.
|
| 34 |
Greenberg A, Verbalis JG. Vasopressin receptor antagonists[J]. Kidney Int, 2006, 69: 2124-2130.
|
| 35 |
Verbalis JG, Grossman A, Hoybye C, et al. Review and analysis of differing regulatory indications and expert panel guidelines for the treatment of hyponatremia[J]. Curr Med Res Opin 2014, 30: 1201-1207.
|
| 36 |
Murphy T, Dhar R, Diringer M. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit[J]. Neurocrit Care, 2009, 11: 14-19.
|
| 37 |
Palmer BF, Rock AD, Woodward EJ. Dose comparison of conivaptan (Vaprisol ®) in patients with euvolemic or hypervolemic hyponatremia-efficacy, safety, and pharmacokinetics[J]. Drug Des Devel Ther, 2016, 10: 339-351.
|
| 38 |
任成山，钱桂生. 动脉血气分析与酸碱失衡判断进展及其临床意义[J/CD]. 中华肺部疾病杂志(电子版), 2010, 3(2): 125-145.
|